GB201707106D0 - Viral antigens - Google Patents

Viral antigens

Info

Publication number
GB201707106D0
GB201707106D0 GBGB1707106.9A GB201707106A GB201707106D0 GB 201707106 D0 GB201707106 D0 GB 201707106D0 GB 201707106 A GB201707106 A GB 201707106A GB 201707106 D0 GB201707106 D0 GB 201707106D0
Authority
GB
United Kingdom
Prior art keywords
viral antigens
antigens
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1707106.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB1707106.9A priority Critical patent/GB201707106D0/en
Publication of GB201707106D0 publication Critical patent/GB201707106D0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
GBGB1707106.9A 2017-05-04 2017-05-04 Viral antigens Ceased GB201707106D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1707106.9A GB201707106D0 (en) 2017-05-04 2017-05-04 Viral antigens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1707106.9A GB201707106D0 (en) 2017-05-04 2017-05-04 Viral antigens

Publications (1)

Publication Number Publication Date
GB201707106D0 true GB201707106D0 (en) 2017-06-21

Family

ID=59065500

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1707106.9A Ceased GB201707106D0 (en) 2017-05-04 2017-05-04 Viral antigens

Country Status (1)

Country Link
GB (1) GB201707106D0 (en)

Similar Documents

Publication Publication Date Title
IL268517A (en) Anti-tigit antibodies
ZA201905966B (en) Anti-lag3 antibodies
IL272227A (en) Anti-tigit antibodies
IL267949A (en) Altered virus
GB201709808D0 (en) Antibodies
GB201601073D0 (en) Antibodies
SG10201914130VA (en) GARP-TGF-β ANTIBODIES
ZA202002141B (en) Anti-transthyretin antibodies
IL267785A (en) Virus
GB201603291D0 (en) Antibodies
GB201720970D0 (en) Antibodies
ZA202103456B (en) Anti-alpha-synuclein antibodies
IL271067A (en) Anti-trkb antibodies
GB201820983D0 (en) Virus
EP3500280A4 (en) Viral vaccines
EP3423090C0 (en) Novel influenza antigens
GB201711785D0 (en) Antibodies
GB201707106D0 (en) Viral antigens
GB201707093D0 (en) Viral antigens
GB201716047D0 (en) Virus
GB201717006D0 (en) Anti-OPG antibodies
GB201700259D0 (en) Virus
GB201709818D0 (en) Antibodies
AU2016903295A0 (en) Viral Vaccines
GB201703071D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)